COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 1626: Articles 16251-16260  | Next

A rapid, cost efficient and simple method to identify current SARS-CoV-2 variants of concern by Sanger sequencing part of the spike protein gene
Joergensen, T. S., Blin, K., Kuntke, F., Salling, H. K., Michaelsen, T. Y., Albertsen, M., Larsen, H.
10.1101/2021.03.27.21252266 — Posted: 2021-03-29
IL-6 and D-Dimer at Admission Predicts Cardiac Injury and Early Mortality during SARS-CoV-2 Infection
Si, D., Du, B., Yang, B., Jin, L., Ni, L., Zhang, Q., Zhang, Z., Azam, M. A., Lai, P. F. H., Masse, S., Sun, H., Wang, X., Epelman, S., Lawler, P. R., Yang, P., Nanthakumar, K.
10.1101/2021.03.22.21254077 — Posted: 2021-03-29
Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19
Dean, M. J., Ochoa, J. B., Sanchez-Pino, M., Zabaleta, J., Garai, J., del Valle, L., Wyczechowska, D., Buckner Baiamonte, L., Philbrook, P., Majumder, R., Vander Heide, R., Dunkenberger, L., Thylur, R., Nossaman, R., Roberts, W. M., Chapple, A., Collins, J., Luke, B., Johnson, R., Koul, H., Rees, C. A., Morris, C. R., Garcia-Diaz, J., Ochoa, A. C.
10.1101/2021.03.26.21254441 — Posted: 2021-03-29
De novo Powered Air-Purifying Respirator Design and Fabrication for Pandemic Response
Kothakonda, A., Atta, L., Plana, D., Ward, F., Davis, C., Cramer, A., Moran, R., Freake, J., Tian, E., Mazor, O., Gorelik, P., Van, C., Hansen, C., Yang, H., Sinha, M. S., Li, J., Yu, S. H., LeBoeuf, N. R., Sorger, P. K.
10.1101/2021.03.25.21252076 — Posted: 2021-03-29
A randomized controlled trial of a video intervention shows evidence of increasing COVID-19 vaccination intention
Witus, L. S., Larson, E.
10.1101/2021.03.26.21254433 — Posted: 2021-03-29
Logistic Formula in Biology and Its Application to COVID-19 in Japan
Saito, T., Kokado, A.
10.1101/2021.03.24.21254279 — Posted: 2021-03-29
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines
Kennedy, N. A., Lin, S., Goodhand, J. R., Chanchlani, N., CLARITY IBD Contributors, , Powell, N., Ahmad, T.
10.1101/2021.03.25.21254335 — Posted: 2021-03-28 Discussion: Onsite
A unique SARS-CoV-2 spike protein P681H strain detected in Israel
Zuckerman, N. S., Fleishon, S., Bucris, E., Bar-Ilan, D., Linial, M., Bar-Or, I., Indenbaum, V., Weil, M., Israel National Consortium for SARS-CoV-2 sequencing, , Mendelson, E., Mandelboim, M., Mor, O.
10.1101/2021.03.25.21253908 — Posted: 2021-03-28
Early experiences of rehabilitation for patients post-COVID to improve fatigue, breathlessness exercise capacity and cognition.
Daynes, E., Gerlis, C., Chaplin, E., Gardiner, N., Singh, S. J.
10.1101/2021.03.25.21254293 — Posted: 2021-03-28
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
Jablonska, K., Aballea, S., Auquier, P., Toumi, M.
10.1101/2021.03.25.21254289 — Posted: 2021-03-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).